23andMe (ME) has been quietly exploring a possible sale of its telehealth business, Lemonaid, according to Business Insider. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on ME: 23andMe launches Discover23 to help accelerate genetics research 23andMe, Mirador enter strategic research collaboration
